Zhao, Y., Griesel, R., Omar, Z., Simmons, B., Hill, A., van Zyl, G., . . . Meintjes, G. (2023). Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: A noncomparative, double-blind, randomized placebo-controlled trial. Oxford University Press.
Citación estilo ChicagoZhao, Y., R. Griesel, Z. Omar, B. Simmons, A. Hill, G. van Zyl, C. Keene, G. Maartens, and G. Meintjes. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.
Cita MLAZhao, Y., et al. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.